Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun 29;12(7):1591.
doi: 10.3390/diagnostics12071591.

Non-Invasive Prenatal Screening: The First Report of Pentasomy X Detected by Plasma Cell-Free DNA and Karyotype Analysis

Affiliations
Case Reports

Non-Invasive Prenatal Screening: The First Report of Pentasomy X Detected by Plasma Cell-Free DNA and Karyotype Analysis

Luigia De Falco et al. Diagnostics (Basel). .

Abstract

Pentasomy X is a sex chromosome anomaly caused by the presence of three extra X chromosomes in females (49,XXXXX instead of 46,XX) and is probably due to a nondisjunction during the meiosis. So far, only five cases prenatally diagnosed were described. The main features in 49,XXXXX karyotype include severe intellectual disability with delayed speech development, short stature, facial dysmorphisms, osseous and articular abnormalities, congenital heart malformations, and skeletal and limb abnormalities. Prenatal diagnosis is often difficult due to the lack of a clear echographic sign like nuchal translucency (NT), and mostly cases were postnatally described. We report the first case of a 49,XXXXX female that was detected by non-invasive prenatal screening (NIPS), quantitative fluorescence polymerase chain reaction (QF-PCR) and a fetal karyotype.

Keywords: karyotype; non-invasive prenatal screening (NIPS); prenatal screening; quantitative fluorescent-polymerase chain reaction (QF-PCR); sex chromosome anomaly.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cytogenetics characterization of amniotic fluid. (A) QF-PCR analysis. Informative STR markers on all autosomal chromosomes demonstrate a normal 1:1 marker ratio. The presence of AMELX and the absence of AMELY and SRY is consistent with female gender. The T1 and T3 markers are non-polymorphic (non-STR) X chromosome counting markers that may be used to determine the number of X chromosomes. The abnormal marker ratio (1:5) of the X chromosome counting markers (T1 and T3) is consistent with an abnormal female X chromosome dosage. Informative X chromosomal STR markers (X1, X3, X9) demonstrate abnormal marker ratios, and is consistent with the dosage of more than three X chromosomes. Informative pseudoautosomal STR markers (XY2 and XY3) demonstrate an abnormal (4:1) marker ratio; (B) GTG banding analysis of amniotic fluid show a 49,XXXXX karyotype.
Figure 1
Figure 1
Cytogenetics characterization of amniotic fluid. (A) QF-PCR analysis. Informative STR markers on all autosomal chromosomes demonstrate a normal 1:1 marker ratio. The presence of AMELX and the absence of AMELY and SRY is consistent with female gender. The T1 and T3 markers are non-polymorphic (non-STR) X chromosome counting markers that may be used to determine the number of X chromosomes. The abnormal marker ratio (1:5) of the X chromosome counting markers (T1 and T3) is consistent with an abnormal female X chromosome dosage. Informative X chromosomal STR markers (X1, X3, X9) demonstrate abnormal marker ratios, and is consistent with the dosage of more than three X chromosomes. Informative pseudoautosomal STR markers (XY2 and XY3) demonstrate an abnormal (4:1) marker ratio; (B) GTG banding analysis of amniotic fluid show a 49,XXXXX karyotype.

References

    1. Cho Y.G. A Case of 49,XXXXX in Which the Extra X Chromosomes Were Maternal in Origin. J. Clin. Pathol. 2004;57:1004–1006. doi: 10.1136/jcp.2004.017475. - DOI - PMC - PubMed
    1. Cheng P.J., Chueh H.Y., Shaw S.W., Hsu J.J., Hsieh T.T., Soong Y.K. X Pentasomy in an Intracytoplasmic Sperm Injection Pregnancy Detected by Nuchal Translucency Testing. Fetal Diagn. Ther. 2008;24:299–303. doi: 10.1159/000158653. - DOI - PubMed
    1. Kleczkowska A., Fryns J.P., Van den Berghe H. X-Chromosome Polysomy in the Male: The Leuven Experience 1966–1987. Hum. Genet. 1988;80:16–22. doi: 10.1007/BF00451449. - DOI - PubMed
    1. Pirollo L.M.A., Salehi L.B., Sarta S., Cassone M., Capogna M.V., Piccione E., Novelli G., Pietropolli A. A New Case of Prenatally Diagnosed Pentasomy X: Review of the Literature. Case Rep. Obstet. Gynecol. 2015;2015:935202. doi: 10.1155/2015/935202. - DOI - PMC - PubMed
    1. Boeck A., Gfatter R., Braun F., Fritz B. Pentasomy X and Hyper IgE Syndrome: Co-Existence of Two Distinct Genetic Disorders. Eur. J. Pediatr. 1999;158:723–726. doi: 10.1007/s004310051187. - DOI - PubMed

Publication types